Patent · US Active

2-aryl selenazole compound and pharmaceutical composition thereof

US9802907B2 · kind B2 · utility

0Cited by

0References

21Claims

0Family size

Assignee

Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd. · CN

Inventors

Dongfang SHI · Fremont, US
Changjin FU · Suzhou, CN
Jie Wu · Freeport, US
Jun Liu · 安丰镇, CN

Key dates

Filing date	Nov 24, 2013
Grant date	Oct 31, 2017
Priority date	—
Expiry date	Nov 24, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D495/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A 2-aryl selenazole compound and a pharmaceutical composition are disclosed, wherein the 2-aryl selenazole compound is a compound represented by formula (I) or a pharmaceutically acceptable salt thereof. The 2-aryl selenazole compound has the activity of inhibiting xanthine oxidase. The compound or a pharmaceutically acceptable salt thereof can be applied in terms of preparing a drug used for prevention or treatment of hyperuricemia, gout, diabetic nephropathy, an inflammatory disease or a neurological disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.